![[Toyota Times] Century as a Brand, Lexus as Innovation: All the Details on Toyota's New Project!](https://businessfortnight.com/wp-content/uploads/2025/10/Toyota-Times-Century-as-a-Brand-Lexus-as-Innovation-All-218x150.jpg "[Toyota Times] Century as a Brand, Lexus as Innovation: All the Details on Toyota's New Project!")
Parma, Italy:
The world’s first start-up to assist pharmaceutical corporations in each side of medical hashish growth and distribution is Italian. Named GQC – Glocal Quality Cannabis, it’s considered one of the federated corporations of PQE Group, a world life sciences consulting large that, for nearly 25 years, has been supporting main corporations in all phases of the drug life cycle, from molecule creation to distribution.
Engineering, GxP high quality compliance, regulatory affairs, medical-scientific advisory, scientific research and a GQC academy: these are the main providers that GQC will make accessible to shoppers via the important data gained by PQE Group over greater than 20 years.
This press launch options multimedia. View the full launch right here: https://www.businesswire.com/news/home/20221024005107/en/
“This new project represents an important challenge for me. I strongly believe in the therapeutic power of cannabis in the medical world,’ said Gilda D’Incerti, PQE Group CEO & Founder and President of GQC. “I wanted to support the field of research as well as the development and dissemination of medical cannabis through the creation of this new start-up. I personally, and with great care, researched the professionals who make up the new GQC team: chemists, pharmacists, physicians, and biologists who take care of the supply chain at three hundred and sixty degrees.”
However, the market nonetheless struggles with fragmented and typically obscure nationwide laws. This is exactly the place GQC’s modern proposal suits in, which is able to apply the highest worldwide requirements domestically to at all times assure efficacy, security, and high quality to the finish affected person.
“I believe that medical cannabis should be treated the same as any other pharmaceutical product. Our vision is to support the development of new therapies through effective management of data quality by accelerating the registration of cannabis products and reducing the timing of the supply chain to be faster for the patients,” Riccardo Salvagnini, GQC VP Executive, said during the start-up’s launch ceremony. “Therefore, we want to provide effective technological solutions to medical cannabis products to accelerate our go-to-market strategy through a local approach but with a global mindset. Our quality services support each process and technology to navigate regulations worldwide and provide access to medicines faster and more efficiently. Too often,” Salvagnini concludes, “patients still have difficulty finding these drugs due to a lack of availability of the raw material, which undermines their right to access care.”
View supply model on businesswire.com: https://www.businesswire.com/news/home/20221024005107/en/
